ArticleGenetics in medicine open2026
Epigenetic age and neurodevelopmental outcomes in children born preterm.
Article in Genetics in medicine open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroprognostication in infants born preterm at the limits of viability: assessment under uncertainty.Pediatric research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The objective of this study was to identify predictors of epigenetic age and its association with neurodevelopmental outcomes in children born preterm. Methods: A prospective cohort of children born 24-to-32-weeks gestation, well characterized with clinical data, brain imaging, and neurodevelopmental assessments at 3 years (Bayley-III cognitive and motor composite), were included. Epigenetic age (in weeks) was determined using the Pediatric Buccal Epigenetic Clock and corrected for chronological age to give epigenetic age difference (EAD). The associations between EAD, clinical risk factors and neurodevelopmental outcomes were examined using multivariable linear regression. Results: A total of 102 study participants (47% males) were included. Epigenetic age showed a positive association with chronological age at term-equivalent age and 3 years. Neonatal morbidity was associated with a lower EAD (epigenetic age deceleration) at 3 years (β = -10.1, Conclusion: Epigenetic age acceleration was associated with better cognitive and motor outcomes in children born preterm. Epigenetic modification is an important biological mechanism that contributes to the variability in neurodevelopmental outcomes in the preterm population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.